univariable | multivariable | |||||||
---|---|---|---|---|---|---|---|---|
Wald | OR | 95% CI | P | Wald | OR | 95% CI | P | |
Donor related | ||||||||
Age [years] | 1.79 | 1.02 | 0.99–1.04 | 0.18 | ||||
Sodium [mmol/L] | 3.92 | 1.05 | 1.00–1.10 | 0.048 | 3.74 | 1.06 | 1.0–1.13 | 0.053 |
ALT [U/L] | 0.94 | 1.00 | 0.99–1.00 | 0.76 | ||||
AST [U/L] | 0.17 | 1.00 | 0.99–1.00 | 0.68 | ||||
Bilirubine [mg/dL] | 0.28 | 0.92 | 0.68–1.24 | 0.60 | ||||
CIT [h] | 4.09 | 1.19 | 1.05–1.41 | 0.04 | 1.62 | 1.14 | 0.93–1.38 | 0.20 |
WIT [min] | 3.54 | 1.05 | 0.99–1.11 | 0.06 | ||||
visual assessment by surgeona | ||||||||
acceptable | 11.03 | 13.14 | 2.87–60.03 | 0.001 | 9.21 | 12.23 | 2.43–61.59 | 0.002 |
poor | 6.27 | 14.6 | 1.79–118.9 | 0.01 | 5.34 | 13.40 | 1.48–121.1 | 0.02 |
steatosis (histological)b | ||||||||
stage 2 | 0.36 | 1.58 | 0.36–6.93 | 0.55 | ||||
stage 3 | 1.38 | 3.79 | 0.41–34.97 | 0.42 | ||||
Recepient related | ||||||||
labMELD | 0.05 | 1.00 | 0.97–1.04 | 0.82 | ||||
PoHT | 6.78 | 2.91 | 1.30–6.50 | < 0.01 | 2.15 | 2.07 | 0.78–5.48 | 0.14 |
NE dosage before reperfusion [0.1 μg kg−1 min−1] | 7.86 | 2.00 | 1.23–3.24 | 0.01 | 7.56 | 2.20 | 1.26–3.86 | 0.01 |